Previous Article | Next Article ![]()
J. Virol., Apr 1995, 2187-2193, Vol 69, No. 4
D Moskophidis and RM Zinkernagel
Infection with virus variants exhibiting changes in the peptide sequences
defining immunodominant determinants that abolish recognition by antiviral
cytotoxic T cells (CTL) presents a considerable challenge to the antiviral
T-cell immune system and may enable some viruses to persist in hosts. The
potential importance of such variants with respect to mechanisms of viral
persistence and disease pathogenesis was assessed by infecting adult mice
with variants of lymphocytic choriomeningitis virus (LCMV) strain WE. These
variants were selected in vivo or in vitro for resistance to lysis by CD8+
H-2b-restricted antiviral CTL. The majority of anti-LCMV CTL in infected
H-2b mice recognize epitopes defined by residues 32 to 42 and 275 to 289
(epitopes 32-42 and 275-289) of the LCMV glycoprotein or 397 to 407 of the
viral nucleoprotein. The 8.7 variant exhibits a change in the epitope 32-42
(Val-35-->Leu), and variant CL1.2 exhibits a change in the epitope
275-289 (Asn-280-->Asp) of the wild-type LCMV-WE. The double-mutated
8.7-B23 variant had the variation of 8.7 and an additional change located
in the epitope 275-289 (Asn-280-->Ser). The 8.7 variant peptide with
unchanged anchor positions bound efficiently to H-2Db and H-2Kb molecules
but induced only a very weak CTL response. CTL epitope 275-289 of CL1.2 and
8.7-B23 altered at predicted anchor residues were unable to bind Db
molecules and were also not recognized by antiviral CTL. Infection of
C57BL/6 mice (H-2b) with the variants exhibiting mutations of one of the
CTL epitopes, i.e., 8.7 or CL1.2, induced CTL responses specific for the
unmutated epitopes comparable with those induced by infection with WE, and
these responses were sufficient to eliminate virus from the host. In
contrast, infection with the double-mutated variant 8.7-B23 induced CTL
activity that was reduced by a factor of about 50-fold compared with
wild-type LCMV. Consequently, high doses (10(7) PFU intravenously) of this
virus were eliminated slowly and only by about day 100 after infection.
8.7-B23 failed to cause lethal lymphocytic choriomeningitis after
intracerebral infection with a dose of > 10(4) PFU in C57BL/6 mice (but
not in mice of nonselecting H-2d haplotype); with the other variants or
wild-type LCMV, doses greater than 10(6) to 10(7) PFU were necessary to
avoid lethal choriomeningitis.(ABSTRACT TRUNCATED AT 400 WORDS)
Copyright © 1995, American Society for Microbiology
Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus
Department of Pathology, University of Zurich, Switzerland.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|